Androgen-deprivation therapy is associated with Alzheimer's disease

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Androgen-deprivation therapy (ADT) in patients with prostate cancer is associated with the development of Alzheimer's disease.

Why this matters

  • Clinicians considering treating prostate cancer with ADT may also want to consider the patient's risk for Alzheimer's disease as well...